Edwards Lifesciences stock last at USD 86.52, up 0.92 percent in New York trading
Published on 09/25/2026 at 20:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edwards Lifesciences was last at USD 86.52 in New York trading on September 25, 2026, up USD 0.79 or 0.92 percent from USD 85.73. The S&P 500 was at 7,751.10, up 0.68 percent at 12:09 p.m. ET, putting the shares 0.24 percentage points ahead. The next five trading days include US inflation and employment data.
The September 25, 2026 session in figures
Edwards Lifesciences Corporation (ISIN US28176E1082, NYSE: EW) opened at USD 85.65 on September 25, 2026. The shares reached a session high of USD 87.11 and a session low of USD 84.92. Edwards Lifesciences was last at USD 86.52 at 2:26 p.m. ET, with 1,557,195 shares traded.
The stock stood USD 9.77 below its 52-week high of USD 96.29 and USD 14.22 above its 52-week low of USD 72.30. The intraday range measured USD 2.19 from low to high. The shares advanced USD 0.79 from the prior session level, while the S&P 500 gained 0.68 percent at 12:09 p.m. ET.
Market momentum and rate sensitivity on September 25, 2026
US equities traded higher as oil prices slipped during the session. Investopedia reported that the Nasdaq and S&P 500 had gained 1.6 percent and 0.7 percent for the week, respectively, before the session finished.
Rising Treasury yields remained a broader market consideration after the 30-year yield reached 5.501 percent during the prior session. Close Look said the 30-year yield stood at 5.461 percent and the 10-year yield at 5.162 percent in its September 25 market review. Edwards Lifesciences gained while Abbott Laboratories fell 0.04 percent and Medtronic declined 0.32 percent at 2:26 p.m. ET.
S&P 500 and medical-device peers on September 25, 2026
The S&P 500 stood at 7,751.10, up 0.68 percent, at 12:09 p.m. ET. The Nasdaq 100 was at 30,668.85, up 0.75 percent, at 12:09 p.m. ET. FX Empire listed those levels during the US session. Stryker gained 1.18 percent to USD 272.93 at 2:26 p.m. ET, giving Edwards Lifesciences a 0.26 percentage point performance lead over that peer.
PCE inflation and jobs data through October 2, 2026
US JOLTS job openings data is scheduled for September 29 at 10:00 a.m. ET, providing a labor-market indicator for rate-sensitive shares. US personal income, outlays and PCE inflation data are scheduled for September 30 at 8:30 a.m. ET. Kiplinger lists the September employment report for October 2 at 8:30 a.m. ET, extending the macro focus into the following session.
